CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
for front line treatment of locally-advanced pancreatic adenocarcinoma.The device is an experimental, portable, battery operated device for ...
Phase 3
Fountain Hill, Pennsylvania, United States and 197 other locations
to evaluate the safety and efficacy of first-line chemo-immunotherapy combinations in participants with metastatic pancreatic ductal adenocarcinoma...
Phase 1
Philadelphia, Pennsylvania, United States and 5 other locations
The main purpose of this study is to look at the effectiveness, safety, and anti-tumor activity (preventing growth of the tumor) of the drugs Nirapar...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States
The goal of this clinical trial is to determine clinical advantages for LP-300 in combination with carboplatin and pemetrexed in the never smoker pat...
Phase 2
Philadelphia, Pennsylvania, United States of America and 8 other locations
The purpose of this study is to test any good and bad effects of the study drug called PEGPH20. PEGPH20 alone is considered investigational. The Food...
Allentown, Pennsylvania, United States and 9 other locations
as First-Line or Second-Line Therapy in Adult Patients with Inoperable, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma...
Phase 2
Philadelphia, Pennsylvania, United States of America and 47 other locations
adenocarcinoma (GEA), biliary tract cancer (BTC), or colorectal cancer (CRC)....
Phase 2
Philadelphia, Pennsylvania, United States of America and 20 other locations
participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSignatur...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States of America and 67 other locations
after complete surgical resection (R0) in participants with Stage I adenocarcinoma NSCLC who are ctDNA-positive, as determined by the Sponso...
Phase 3
Philadelphia, Pennsylvania, United States and 138 other locations
and safety of AZD0901 compared to Investigator's choice of therapy as 2L+ treatment for participants with advanced or metastatic gastric or GEJ adenocarcinoma...
Phase 3
Philadelphia, Pennsylvania, United States and 165 other locations
Clinical trials
Research sites
Resources
Legal